Knight Therapeutics

(OTC) KHTRF

Current Price$6.76

Market Cap$662.71M

Since IPO (2014)+22%

5 Year+56%

1 Year+52%

1 Month+11%

Knight Therapeutics Financials at a Glance

Market Cap

$662.71M

Revenue (TTM)

CA$510.90M

Net Income (TTM)

CA$5.43M

EPS (TTM)

$0.04

P/E Ratio

159.43

Dividend

$0.00

Beta (Volatility)

0.07 (Low)

Dividend

$0.00

Beta (Volatility)

0.07 (Low)

Price

$6.76

Volume

2,908

Open

$6.84

Price

$6.76

Volume

2,908

Open

$6.84

Previous Close

$6.76

Daily Range

$6.76 - $6.84

52-Week Range

$4.07 - $6.84

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

0.07 (Low)

Price

$6.76

Volume

2,908

Open

$6.84

Previous Close

$6.76

Daily Range

$6.76 - $6.84

52-Week Range

$4.07 - $6.84

Estimated Earnings Date

Aug 6, 2026

KHTRF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Knight Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

830

CEO

Samira Sakhia, MBA

Website

www.gud-knight.com

Headquarters

Montreal, QC H3Z 3B8, CA

KHTRF Financials

Key Financial Metrics (TTM)

Gross Margin

37%

Operating Margin

Net Income Margin

Return on Equity

73%

Return on Capital

Return on Assets

Earnings Yield

0.63%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$662.71M

Shares Outstanding

98.03M

Volume

2.91K

Avg. Volume

9.33K

Financials (TTM)

Gross Profit

CA$150.62M

Operating Income

-CA$2.20M

EBITDA

CA$54.32M

Operating Cash Flow

CA$70.25M

Capital Expenditure

-CA$1.91M

Free Cash Flow

CA$68.34M

Cash & ST Invst.

CA$95.21M

Total Debt

CA$77.85M

Knight Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

CA$148.82M

+69.0%

Gross Profit

CA$54.58M

+56.5%

Gross Margin

36.67%

N/A

Market Cap

$662.71M

N/A

Market Cap/Employee

$889.55K

N/A

Employees

745

N/A

Net Income

CA$13.20M

+504.3%

EBITDA

CA$26.84M

+107.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

CA$127.62M

-29.4%

Total Debt

CA$69.96M

+29.7%

Accounts Receivable

CA$157.02M

+25.1%

Inventory

CA$142.28M

+1.5%

Long Term Debt

CA$48.29M

+62.6%

Short Term Debt

CA$21.66M

-10.5%

Return on Assets

0.52%

N/A

Return on Invested Capital

1.54%

N/A

Free Cash Flow

CA$37.22M

+120154.6%

Operating Cash Flow

CA$40.55M

+1004.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AGYTFAllergy Therapeutics plc

AGYTFAllergy Therapeutics plc$0.13+0.00%

VRNOFVerano Holdings Corp.

VRNOFVerano Holdings Corp.$1.30+8.33%

PTCHFPureTech Health plc

PTCHFPureTech Health plc$1.70+0.00%

VHIBFVitalhub Corp.

VHIBFVitalhub Corp.$5.15+2.22%

CRLBFCresco Labs Inc.

CRLBFCresco Labs Inc.$0.82-3.53%

BOVNFBioInvent International AB (publ)

BOVNFBioInvent International AB (publ)$3.29+0.00%

SUSRFSurgical Science Sweden AB (publ)

SUSRFSurgical Science Sweden AB (publ)$4.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

Questions About KHTRF

What is the current price of Knight Therapeutics?

Knight Therapeutics is trading at $6.76 per share.

What is the 52-week range for Knight Therapeutics?

Over the past 52 weeks, Knight Therapeutics has traded between $4.07 and $6.84.

How much debt does Knight Therapeutics have?

As of the most recent reporting period, Knight Therapeutics reported total debt of CA$50.00M.

How much cash does Knight Therapeutics have on hand?

Knight Therapeutics reported CA$77.42M in cash and cash equivalents in its most recent financial results.

What is Knight Therapeutics’s dividend yield?

Knight Therapeutics does not currently have a dividend yield.

Knight Therapeutics

Knight Therapeutics Financials at a Glance

KHTRF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Knight Therapeutics

KHTRF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Knight Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About KHTRF

What is the current price of Knight Therapeutics?

What is the 52-week range for Knight Therapeutics?

How much debt does Knight Therapeutics have?

How much cash does Knight Therapeutics have on hand?

What is Knight Therapeutics’s dividend yield?

Premium Investing Services